Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
1979-11-21
|
| pubmed:language |
rus
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0042-4609
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
3-9
|
| pubmed:dateRevised |
2005-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:39391-Cell Division,
pubmed-meshheading:39391-HLA Antigens,
pubmed-meshheading:39391-Humans,
pubmed-meshheading:39391-Methoxsalen,
pubmed-meshheading:39391-Neurotransmitter Agents,
pubmed-meshheading:39391-Papaverine,
pubmed-meshheading:39391-Psoriasis,
pubmed-meshheading:39391-Ultraviolet Therapy
|
| pubmed:year |
1979
|
| pubmed:articleTitle |
[Present-day status of the problem of psoriasis and the tasks of its development].
|
| pubmed:publicationType |
Journal Article,
Review
|